Arista Networks vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

Arista Networks leads in AI visibility (99 vs 90)

Arista Networks

LeaderCloud Infrastructure

High Speed Networking

Santa Clara cloud networking (NYSE: ANET) at $7.0B FY2024 revenue (+20%); AI networking +50%, 400G/800G GPU cluster switches for Microsoft/Meta/Google competing with Cisco and NVIDIA InfiniBand for AI data center fabric.

AI VisibilityBeta
Overall Score
A99
Category Rank
#1 of 2
AI Consensus
76%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
99

About

Arista Networks, Inc. is a Santa Clara, California-based cloud networking company — publicly traded on the New York Stock Exchange (NYSE: ANET) as an S&P 500 Information Technology component with a market capitalization of approximately $120 billion — designing and selling programmable Ethernet switches, routers, and network management software for cloud data centers, artificial intelligence compute clusters, and enterprise campus networks through approximately 4,400 employees worldwide. In fiscal year 2024, Arista reported revenue of $7.0 billion (+20% year-over-year), with AI networking revenue growing more than 50% as hyperscale customers (Microsoft, Meta, Google) deployed Arista's 400G and 800G Ethernet switches as the network fabric interconnecting tens of thousands of NVIDIA H100 and H200 GPUs in AI training clusters. CEO Jayshree Ullal has led Arista since 2008, executing the strategy of building the world's most advanced Ethernet switching operating system (EOS, Extensible Operating System) and using EOS's programmability and reliability advantages to win the hyperscale cloud data center market from Cisco — a share gain that created Arista's growth from a startup to a $7B+ revenue company in a decade. Arista's EOS software runs across the entire product family (campus, data center, AI cluster switches) with a single code base and management plane, enabling network operators to write Python scripts and custom automation for every switch in the network from one operating system.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

99
Overall Score
90
#1
Category Rank
#9
76
AI Consensus
60
stable
Trend
stable
99
ChatGPT
99
99
Perplexity
99
99
Gemini
83
99
Claude
96
90
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.